Several endocrinological alterations have been described in patients with obesity, including a decrease in growth hormone (GH) and insulin-like growth factor (IGF-1) levels [5, 6], hypogonadism [7], and an increase in thyroid-stimulating hormone (TSH) levels [8]. This evidence concerns the gene GH1 and obesity due to melanocortin 4 receptor deficiency.